Somatic cell reprogramming for Parkinson's disease treatment.
Xiaozhuo Li1, Kevin Fang2, Fengping Wang3
1School of Institute of Primate Translational Medicine Kunming University of Science and Technology Kunming China.
Ibrain
|March 19, 2025
Summary
Cell reprogramming offers a novel therapeutic strategy for Parkinson's disease (PD) by generating dopamine neurons. This review explores its potential, methods, and limitations for PD treatment.
Area of Science:
- Neuroscience
- Regenerative Medicine
Background:
- Parkinson's disease (PD) involves dopamine neuron degeneration, leading to motor deficits and reduced quality of life.
- Current treatments like L-DOPA and deep brain stimulation offer limited long-term benefits for PD progression.
Purpose of the Study:
- To review cell reprogramming as a therapeutic strategy for Parkinson's disease.
- To discuss the advantages, methodology, cell origins, efficiency, and limitations of cell reprogramming in PD treatment.
Main Methods:
- Review of existing literature on cell reprogramming techniques for PD.
- Analysis of cell origins, differentiation protocols, and in vivo/in vitro studies.
- Evaluation of transformation efficiency and practical challenges.
Main Results:
- Cell reprogramming shows promise for generating dopamine-producing cells for PD therapy.
- Various cell sources and reprogramming methods are being investigated.
- Challenges remain in achieving efficient and safe clinical application.
Conclusions:
- Cell reprogramming represents a promising frontier in Parkinson's disease treatment.
- Further research is needed to optimize efficiency, safety, and clinical translation.
- Addressing practical application shortcomings is crucial for therapeutic success.
More Related Videos
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:21EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
01:24Parkinson's Disease: Treatment
170
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
170
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:15Parkinson's Disease: Overview
405
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
405